Compounds > iotrolan
Page last updated: 2024-10-29

iotrolan and Coronary Disease

iotrolan has been researched along with Coronary Disease in 2 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schräder, R2
Kaltenbach, M2
Kober, G2
Abel, J1
Sievert, H1
Friedmann, A1

Trials

1 trial available for iotrolan and Coronary Disease

ArticleYear
[Coronary arteriography with a plasma-isotonic roentgen contrast medium: effects on ECG, blood pressure and coronary circulation].
    Zeitschrift fur Kardiologie, 1989, Volume: 78, Issue:1

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Contrast Media; Coronary Angiography; Coronar

1989

Other Studies

1 other study available for iotrolan and Coronary Disease

ArticleYear
Coronary arteriography with iotrolan 280, a blood-isotonic, nonionic, dimeric contrast medium: preliminary clinical results.
    Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband, 1989, Volume: 128

    Topics: Blood Pressure; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Fem

1989